← Leaderboards
Samuel A Wickline
Barnes-Jewish Hospital
$27,546,938
Attributed
$29,160,715
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–19$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$45,622,998 · 20
By mechanism
R01$23,923,828 · 8
U54$17,865,848 · 3
P50$1,950,410 · 1
R21$1,818,031 · 4
P41$64,881 · 4
Top collaborators
- Christine T Pham5 shared
- Bruce Gale3 shared
- Joshua L. Hood3 shared
- John E. Mccarthy2 shared
- Michael Scott Hughes1 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseNanoparticleIntegrinsBlood VesselsIn VivoContrast MediaResponseMagnetic Resonance ImagingImageSignal TransductionInflammatoryInflammationDrug Delivery SystemsAngiogenesisMolecular ImagingDesignMolecularTissuesDoseDiagnosisLigandsFluorocarbonsCellsPathway Interactions
Grant awards (68)
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2019 · AR
Prevention and Treatment of Acute Kidney Injury$503,142
R01 · FY2018 · DK · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2018 · AR
Prevention and Treatment of Acute Kidney Injury$503,142
R01 · FY2017 · DK · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2017 · AR
Anti-Inflammatory Therapeutics for Cardiovascular Disease$441,873
R01 · FY2016 · HL · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2016 · AR
Prevention and Treatment of Acute Kidney Injury$298,322
R01 · FY2016 · DK · contact PI
ANTI-INFLAMMATORY THERAPEUTICS FOR CARDIOVASCULAR DISEASE$238,842
R01 · FY2016 · HL · contact PI
Prevention and Treatment of Acute Kidney Injury$210,689
R01 · FY2016 · DK · contact PI
REAL TIME ULTRASOUND ENTROPY-BASED QUANTIFICATION OF FIBROFATTY LIVER DISEASE$190,625
R21 · FY2016 · EB
ANTI-INFLAMMATORY THERAPEUTICS FOR CARDIOVASCULAR DISEASE$670,504
R01 · FY2015 · HL · contact PI
Prevention and Treatment of Acute Kidney Injury$513,239
R01 · FY2015 · DK · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2015 · AR
REAL TIME ULTRASOUND ENTROPY-BASED QUANTIFICATION OF FIBROFATTY LIVER DISEASE$228,750
R21 · FY2015 · EB · contact PI
Continuous separation of melanoma exosomes using field-flow fractionation$187,762
R21 · FY2015 · GM
ANTI-INFLAMMATORY THERAPEUTICS FOR CARDIOVASCULAR DISEASE$667,101
R01 · FY2014 · HL · contact PI
Continuous separation of melanoma exosomes using field-flow fractionation$187,504
R21 · FY2014 · GM
ENTROPY-BASED TISSUE DISCRIMINATORS$184,300
R21 · FY2014 · EB · contact PI
ANTI-INFLAMMATORY THERAPEUTICS FOR CARDIOVASCULAR DISEASE$648,041
R01 · FY2013 · HL · contact PI
Therapy Nanoparticles for Modulation of Inflammation in Neuromuscular Disease$308,785
R01 · FY2013 · AR · contact PI
ENTROPY-BASED TISSUE DISCRIMINATORS$228,000
R21 · FY2013 · EB
Continuous separation of melanoma exosomes using field-flow fractionation$199,740
R21 · FY2013 · GM
QUANTIFYING KIDNEY INJURY AND INFLAMMATION WITH FLUORINE (19F) MRI$183,350
R21 · FY2013 · DK · contact PI
ANTI-INFLAMMATORY THERAPEUTICS FOR CARDIOVASCULAR DISEASE$698,215
R01 · FY2012 · HL · contact PI
Therapy Nanoparticles for Modulation of Inflammation in Neuromuscular Disease$325,037
R01 · FY2012 · AR · contact PI
QUANTIFYING KIDNEY INJURY AND INFLAMMATION WITH FLUORINE (19F) MRI$228,000
R21 · FY2012 · DK · contact PI
METHODS IN MOLECULAR IMAGING AND TARGETED THERAPEUTICS$1,365,278
R01 · FY2011 · HL · contact PI
Therapy Nanoparticles for Modulation of Inflammation in Neuromuscular Disease$325,037
R01 · FY2011 · AR · contact PI
METHODS IN MOLECULAR IMAGING AND TARGETED THERAPEUTICS$1,402,759
R01 · FY2010 · HL · contact PI
Vascular Imaging Core Laboratory$390,259
P50 · FY2010 · HL · contact PI
Therapy Nanoparticles for Modulation of Inflammation in Neuromuscular Disease$338,580
R01 · FY2010 · AR · contact PI
The Siteman Center of Cancer Nanotechnology Excellence *$3,340,999
U54 · FY2009 · CA · contact PI
Acoustic Nanobeacons for Targeted Detection and Treatment of Tumor Angiogenesis$484,259
U54 · FY2009 · CA · contact PI
Vascular Imaging Core Laboratory$388,444
P50 · FY2009 · HL · contact PI
Administrative Core and "The Center for Applied Nanomedicine"$349,555
U54 · FY2009 · CA · contact PI
THERAPY NANOPARTICLES FOR MODULATION OF INFLAMMATION IN NEUROMUSCULAR DISEASE$342,000
R01 · FY2009 · AR · contact PI
The Siteman Center of Cancer Nanotechnology Excellence *$3,284,302
U54 · FY2008 · CA · contact PI
Methods in Molecular Imaging and Targeted Therapeutics$1,533,584
R01 · FY2008 · HL · contact PI
Vascular Imaging Core Laboratory$381,461
P50 · FY2008 · HL · contact PI
Acoustic Nanobeacons for Targeted Detection and Treatment of Tumor Angiogenesis$331,497
U54 · FY2008 · CA · contact PI
Administrative Core and "The Center for Applied Nanomedicine"$238,254
U54 · FY2008 · CA · contact PI
AUTO MSRMTS OF FIBER ANGLE DIST IN DISARR MYOCARDIUM DURING TX W/ ACE INHIBITOR$16,166
P41 · FY2008 · RR · contact PI
The Siteman Center of Cancer Nanotechnology Excellence *$3,266,643
U54 · FY2007 · CA · contact PI
Methods in Molecular Imaging and Targeted Therapeutics$1,558,175
R01 · FY2007 · HL · contact PI
Vascular Imaging Core Laboratory$396,448
P50 · FY2007 · HL · contact PI
AUTO MSRMTS OF FIBER ANGLE DIST IN DISARR MYOCARDIUM DURING TX W/ ACE INHIBITOR$8,862
P41 · FY2007 · RR · contact PI
The Siteman Center of Cancer Nanotechnology Excellence *$3,307,729
U54 · FY2006 · CA · contact PI
Methods in Molecular Imaging and Targeted Therapeutics$1,531,987
R01 · FY2006 · HL · contact PI
Vascular Imaging Core Laboratory$393,798
P50 · FY2006 · HL · contact PI
AUTO MSRMTS OF FIBER ANGLE DIST IN DISARR MYOCARDIUM DURING TX W/ ACE INHIBITOR$9,830
P41 · FY2006 · RR · contact PI
The Siteman Center of Cancer Nanotechnology Excellence *$3,262,610
U54 · FY2005 · CA
Methods in Molecular Imaging and Targeted Therapeutics$1,495,310
R01 · FY2005 · HL
AUTO MSRMTS OF FIBER ANGLE DIST IN DISARR MYOCARDIUM DURING TX W/ ACE INHIBITOR$9,899
P41 · FY2005 · RR
Methods in Molecular Imaging and Targeted Therapeutics$1,466,075
R01 · FY2004 · HL
ULTRASONIC TISSUE CHARACTERIZATION OF CARDIAC REMODELING$382,500
R01 · FY2004 · HL
AUTO MSRMTS OF FIBER ANGLE DIST IN DISARR MYOCARDIUM DURING TX W/ ACE INHIBITORS$20,124
P41 · FY2004 · RR
Specific Tissue Targeted Ultrasonic Contrast Agent$428,879
R01 · FY2003 · EB
ULTRASONIC TISSUE CHARACTERIZATION OF CARDIAC REMODELING$382,500
R01 · FY2003 · HL
MICROSCOPIC CARDIAC MATERIAL PROPERTIES IN AGING$444,376
R01 · FY2002 · HL
Specific Tissue Targeted Ultrasonic Contrast Agent$434,259
R01 · FY2002 · HL
ULTRASONIC TISSUE CHARACTERIZATION OF CARDIAC REMODELING$358,960
R01 · FY2002 · HL
MICROSCOPIC CARDIAC MATERIAL PROPERTIES IN AGING$433,602
R01 · FY2001 · HL
Specific Tissue Targeted Ultrasonic Contrast Agent$384,057
R01 · FY2001 · HL
ULTRASONIC TISSUE CHARACTERIZATION OF CARDIAC REMODELING$359,920
R01 · FY2001 · HL
MICROSCOPIC CARDIAC MATERIAL PROPERTIES IN AGING$423,143
R01 · FY2000 · HL
ULTRASONIC TISSUE CHARACTERIZATION OF CARDIAC REMODELING$370,000
R01 · FY2000 · HL
SPECIFIC TISSUE TARGETED ULTRASONIC CONTRAST AGENT$322,410
R01 · FY2000 · HL